{"id":26799,"date":"2024-03-15T08:34:42","date_gmt":"2024-03-15T08:34:42","guid":{"rendered":"https:\/\/kraios.app\/news\/saglik\/2024\/03\/15\/zap-x-teknolojisi-tumorlu-hastayi-sagirlik-riskinden-kurtardi\/"},"modified":"2024-03-15T08:34:42","modified_gmt":"2024-03-15T08:34:42","slug":"zap-x-teknolojisi-tumorlu-hastayi-sagirlik-riskinden-kurtardi","status":"publish","type":"post","link":"https:\/\/kraios.app\/news\/saglik\/2024\/03\/15\/zap-x-teknolojisi-tumorlu-hastayi-sagirlik-riskinden-kurtardi\/","title":{"rendered":"&#8220;Zap-X&#8221; teknolojisi, t\u00fcm\u00f6rl\u00fc hastay\u0131 sa\u011f\u0131rl\u0131k riskinden kurtard\u0131"},"content":{"rendered":"<p><\/p>\n<div>\n<p>\u00a0T\u00fcrkiye&#8217;de ilk kez Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesinde hizmete sunulan robotik jiroskopik radyocerrahi cihaz\u0131 Zap-X ile i\u015fitme sinirlerindeki t\u00fcm\u00f6r nedeniyle sa\u011f\u0131rl\u0131k riski bulunan 64 ya\u015f\u0131ndaki hastan\u0131n h\u0131zla ilerleyen i\u015fitme kayb\u0131 engellendi.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/23525b19-4139-468c-8051-ba931b6738e4\/MART%202024%2Fzap1.jpg\"\/><\/p>\n<p>D\u00fcnyadaki 18 Zap-X teknolojisinden biri olan Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi b\u00fcnyesindeki robotik jiroskopik radyocerrahi cihaz\u0131 ile y\u00fcr\u00fct\u00fclen tedaviler, hastalara \u015fifa vermeye ba\u015flad\u0131.<\/p>\n<p>Zap-X ile tedavi olana\u011f\u0131n\u0131 yakalayan ilk hastalardan biri de i\u015fitme ve denge sinirlerinde ortaya \u00e7\u0131kan t\u00fcm\u00f6r ile m\u00fccadele eden 64 ya\u015f\u0131ndaki emekli \u0130ngilizce \u00f6\u011fretmeni G\u00fcnsel Karaca oldu.<\/p>\n<p>Uygulama sayesinde t\u00fcm\u00f6r\u00fcn\u00fcn b\u00fcy\u00fcmesi durdurulan Karaca, duyma yetisini tamamen kaybetme riskinden de kurtuldu.<\/p>\n<h3>&#8220;Cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131 problemli bir t\u00fcm\u00f6r&#8221;<\/h3>\n<p>Zap-X ile y\u00fcr\u00fct\u00fclen radyocerrahi tedavisine ili\u015fkin bilgileri payla\u015fan Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Radyasyon Onkolojisi Ana Bilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. G\u00f6khan \u00d6zyi\u011fit, cihaz\u0131n baz\u0131 \u00f6zellikleri itibar\u0131yla \u00e7ok daha hassas tedavileri yapabildi\u011fini anlatt\u0131.<\/p>\n<p>G\u00fcnsel Karaca&#8217;n\u0131n &#8220;akustik n\u00f6rinom&#8221; olarak adland\u0131r\u0131lan bir t\u00fcm\u00f6r\u00fcn\u00fcn bulundu\u011funu belirten \u00d6zyi\u011fit, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<\/p>\n<p>&#8220;Bu, cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131 problemli, \u00f6zellikle i\u015fitme sinirini tutan bir t\u00fcm\u00f6r. Hastalar, genellikle i\u015fitme kayb\u0131yla bize ba\u015fvuruyor. Bu t\u00fcm\u00f6rlerde o b\u00f6lgede yap\u0131lacak cerrahi i\u015flem, i\u015fitme kayb\u0131n\u0131n daha da artmas\u0131na neden olabiliyor. Zap-X cihaz\u0131yla bu t\u00fcr t\u00fcm\u00f6rleri rahatl\u0131kla tedavi edebiliyoruz. Mevcut i\u015fitme kayb\u0131n\u0131 geriye alam\u0131yoruz belki ama kayb\u0131n daha da ilerlemesini engelleyip, t\u00fcm\u00f6r\u00fcn b\u00fcy\u00fcmesini durma noktas\u0131na getirebiliyoruz.&#8221;<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/23525b19-4139-468c-8051-ba931b6738e4\/MART%202024%2Fzap2.jpg\"\/><\/p>\n<h3>Yar\u0131m saat s\u00fcr\u00fcyor, cerrahi i\u015flem yap\u0131lm\u0131yor<\/h3>\n<p>Prof. Dr. \u00d6zyi\u011fit, akustik n\u00f6rinomun iyi huylu ancak b\u00fcy\u00fcd\u00fc\u011f\u00fcnde beyin sap\u0131na bas\u0131 yapma ve daha ciddi sa\u011fl\u0131k problemlerine yol a\u00e7ma tehlikesi bulunan bir t\u00fcm\u00f6r oldu\u011funun alt\u0131n\u0131 \u00e7izerek, \u015f\u00f6yle devam etti:<\/p>\n<p>&#8220;Hastam\u0131z G\u00fcnsel han\u0131m\u0131n da sa\u011f ve sol taraf\u0131nda yakla\u015f\u0131k 1 santimetre civar\u0131nda akustik n\u00f6rinomu s\u00f6z konusuydu. Sa\u011f tarafta y\u00fczde 11 i\u015fitebilirken, sol taraf\u0131nda da y\u00fczde 20&#8217;lik i\u015fitme kayb\u0131 vard\u0131. Zap-X ile \u00f6nce birini, ertesi g\u00fcn di\u011ferini tedavi etmeyi tercih ettik. Tedavi s\u00fcresi ortalama yar\u0131m saat s\u00fcr\u00fcyor. Yar\u0131m saatlik s\u00fcre\u00e7te herhangi bir ne\u015fter, genel anestezi olmadan hastam\u0131z\u0131n tedavisini ger\u00e7ekle\u015ftiriyoruz. Bu y\u00f6ntemle y\u00fczde 100&#8217;e yak\u0131n hastal\u0131k kontrol\u00fc sa\u011flayabiliyoruz, hastam\u0131z\u0131n i\u015fitmesi de daha k\u00f6t\u00fcye gitmeyecek.&#8221;<\/p>\n<p>Hastalar\u0131n tedavi esnas\u0131nda istedi\u011fi m\u00fczik yay\u0131nlar\u0131n\u0131 dinleyebildi\u011fine ve ayn\u0131 g\u00fcn normal ya\u015famlar\u0131na d\u00f6nd\u00fc\u011f\u00fcne de\u011finen \u00d6zyi\u011fit, Zap-X&#8217;te tedavinin iyonla\u015ft\u0131r\u0131c\u0131 radyasyonla ger\u00e7ekle\u015ftirildi\u011fini ve cerrahi i\u015flemin s\u00f6z konusu olmad\u0131\u011f\u0131n\u0131 vurgulad\u0131.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/23525b19-4139-468c-8051-ba931b6738e4\/MART%202024%2Fzap3.jpg\"\/><\/p>\n<h3>&#8220;Yan etkileri ciddi oranda azalt\u0131yor&#8221;<\/h3>\n<p>Radyasyon Onkolojisi Ana Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Prof. Dr. G\u00f6zde Yaz\u0131c\u0131 da Zap-X&#8217;in yap\u0131s\u0131 nedeniyle \u015fu an sadece ba\u015f ile boynun \u00fcst b\u00f6lgesinde kullan\u0131labildi\u011fini ancak ilerleyen aylarda boynun daha alt b\u00f6lgesine de inebilece\u011fini anlatt\u0131.<\/p>\n<p>Ba\u015f, boyun b\u00f6lgesindeki t\u00fcm\u00f6rler, sinir h\u00fccresi k\u00f6kenli t\u00fcm\u00f6rler, beyin damar yumaklar\u0131 gibi hastal\u0131klar\u0131n tedavisinde Zap-X&#8217;in kullan\u0131labildi\u011fini aktaran Yaz\u0131c\u0131, &#8220;Zap-X&#8217;in en \u00f6nemli y\u00f6n\u00fc, h\u0131zl\u0131 doz d\u00fc\u015f\u00fc\u015f\u00fcyle hastada olu\u015fabilecek yan etkileri ciddi oranda azaltmas\u0131, daha konforlu bir tedavi olana\u011f\u0131 sunmas\u0131. Bu teknoloji baz\u0131 g\u00f6z t\u00fcm\u00f6rlerinde de \u00e7ok avantajl\u0131, k\u00f6t\u00fc huylu g\u00f6z lezyonlar\u0131nda g\u00f6z ve g\u00f6rme korunarak tedavi sa\u011flayabiliyor.&#8221; bilgisini verdi.<\/p>\n<h3>&#8220;\u0130lk \u015fikayetlerim 6 y\u0131l \u00f6nce duyma kayb\u0131yla ba\u015flad\u0131&#8221;<\/h3>\n<p>Hastal\u0131\u011f\u0131ndaki ilerlemenin durdurulmas\u0131ndan b\u00fcy\u00fck mutluluk duydu\u011funu vurgulayan G\u00fcnsel Karaca, &#8220;\u0130lk \u015fikayetlerim 6 y\u0131l \u00f6nce duyma kayb\u0131yla ba\u015flad\u0131. Ba\u015flang\u0131\u00e7ta \u00f6nemsemedim, sonras\u0131nda vertigo ataklar\u0131m, kula\u011f\u0131m\u0131n i\u00e7inde yang\u0131lar, denge sorunlar\u0131 ya\u015famaya ba\u015flad\u0131m.&#8221; ifadelerini kulland\u0131.<\/p>\n<p>Farkl\u0131 uzmanlara gitti\u011fini, duyma kayb\u0131 i\u00e7in i\u015fitme cihaz\u0131 ald\u0131\u011f\u0131n\u0131 ama uzun s\u00fcre kendisine net te\u015fhis konulamad\u0131\u011f\u0131n\u0131 dile getiren Karaca, Hacettepe&#8217;de 1,5 ay \u00f6nce ald\u0131\u011f\u0131 te\u015fhisle tedaviye ba\u015fland\u0131\u011f\u0131n\u0131 kaydetti.<\/p>\n<p>Karaca, &#8220;\u015eu an \u00e7ok mutluyum, aktif bir ya\u015fam\u0131m var, i\u015fitme kayb\u0131m in\u015fallah var olan noktada duracak, t\u00fcm\u00f6r\u00fcn de k\u00fc\u00e7\u00fclece\u011fini umuyorum. Zap-X&#8217;in i\u00e7inde tedavi al\u0131rken hi\u00e7 gerilmedim, gayet iyi ge\u00e7ti. Bana m\u00fczik a\u00e7t\u0131lar. Tedavi ald\u0131ktan sonra herhangi bir yan etki, problem ya\u015famad\u0131m, hayat\u0131ma d\u00f6nd\u00fcm.&#8221; diye konu\u015ftu.<\/p>\n<p>                            <span class=\"detay-foto-editor\">&#13;<br \/>\n                                <a href=\"https:\/\/www.aa.com.tr\/tr\/p\/abonelik-talep-formu\/1001\" target=\"_blank\" style=\"font-size:12px; color:#444; text-decoration:none;\" rel=\"noopener\">&#13;<br \/>\n                                    Anadolu Ajans\u0131 web sitesinde, AA Haber Ak\u0131\u015f Sistemi (HAS) \u00fczerinden abonelere sunulan haberler, \u00f6zetlenerek yay\u0131mlanmaktad\u0131r. <b style=\"color:#1897F7\">Abonelik i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7iniz.<\/b>&#13;<br \/>\n                                <\/a>&#13;<br \/>\n                            <\/span>\n                        <\/div>\n<p><script>\n\t  window.fbAsyncInit = function() {\n\t\tFB.init({\n\t\t  appId: '1855843514662870',\n\t\t  status : true, \/\/ check login status\n\t\t  cookie : true, \/\/ enable cookies to allow the server to access the session\n\t\t  xfbml  : true  \/\/ parse XFBML\n\t\t});\n\t  };<\/p>\n<p>\t  (function() {\n\t\tvar e = document.createElement('script');\n\t\te.src=\"https:\/\/connect.facebook.net\/tr_TR\/all.js\";\n\t\te.async = true;\n\t\tdocument.getElementById('fb-root').appendChild(e);\n\t  }());\n    <\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0T\u00fcrkiye&#8217;de ilk kez Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesinde hizmete sunulan robotik jiroskopik radyocerrahi cihaz\u0131 Zap-X ile i\u015fitme sinirlerindeki t\u00fcm\u00f6r nedeniyle sa\u011f\u0131rl\u0131k riski bulunan 64 ya\u015f\u0131ndaki hastan\u0131n h\u0131zla ilerleyen i\u015fitme kayb\u0131 engellendi. D\u00fcnyadaki 18 Zap-X teknolojisinden biri olan Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi b\u00fcnyesindeki robotik jiroskopik radyocerrahi cihaz\u0131 ile y\u00fcr\u00fct\u00fclen tedaviler, hastalara \u015fifa vermeye ba\u015flad\u0131. Zap-X [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":26800,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[46],"tags":[],"_links":{"self":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts\/26799"}],"collection":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/comments?post=26799"}],"version-history":[{"count":0,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts\/26799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/media\/26800"}],"wp:attachment":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/media?parent=26799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/categories?post=26799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/tags?post=26799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}